Appili Therapeutics Enrolls Participants in Clinical Trials

October 29, 2020

Appili Therapeutics Enrolls Participants in Clinical Trials

Canada-based Appili Therapeutics has enrolled and dosed the first cluster of participants in its Phase II CONTROL COVID-19 clinical trial of favipiravi, developed by FUJIFILM Toyama Chemical. Yourway has a local depot that’s 6,000 square feet conveniently located in Toronto, Canada to better serve the clinical trial needs in the country.

Back to Index

Media

Upcoming Events

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Schedule a Meeting

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Schedule a Meeting

Media

Articles

Case study: Coordinating a complex intercontinental shipment on a short timeline

Open chat

Hello! How can I help you?